These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25110118)

  • 1. Evaluation of viral inactivation of pseudorabies virus, encephalomyocarditis virus, bovine viral diarrhea virus and porcine parvovirus in pancreatin of porcine origin.
    Caruso C; Gobbi E; Biosa T; Andra' M; Cavallazzi U; Masoero L
    J Virol Methods; 2014 Nov; 208():79-84. PubMed ID: 25110118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
    Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
    J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of enveloped and non-enveloped viruses in the process of chemical treatment and gamma irradiation of bovine-derived grafting materials.
    Lee KI; Lee JS; Jung HH; Lee HY; Moon SH; Kang KT; Shim YB; Jang JW
    Xenotransplantation; 2012; 19(6):365-9. PubMed ID: 23198732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of spray-drying to reduce infectivity of pseudorabies and porcine reproductive and respiratory syndrome (PRRS) viruses and seroconversion in pigs fed diets containing spray-dried animal plasma.
    Polo J; Quigley JD; Russell LE; Campbell JM; Pujols J; Lukert PD
    J Anim Sci; 2005 Aug; 83(8):1933-8. PubMed ID: 16024714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
    Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
    J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a molecular method for hepatitis E virus (HEV) detection in pancreatin of porcine origin.
    Modesto P; Maniaci MG; Cavallazzi U; Acutis PL; Peletto S
    J Virol Methods; 2020 Feb; 276():113790. PubMed ID: 31770544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partitioning and inactivation of viruses by the caprylic acid precipitation followed by a terminal pasteurization in the manufacturing process of horse immunoglobulins.
    Mpandi M; Schmutz P; Legrand E; Duc R; Geinoz J; Henzelin-Nkubana C; Giorgia S; Clerc O; Genoud D; Weber T
    Biologicals; 2007 Oct; 35(4):335-41. PubMed ID: 17470396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of surface-dried virus to common disinfection procedures.
    Terpstra FG; van den Blink AE; Bos LM; Boots AG; Brinkhuis FH; Gijsen E; van Remmerden Y; Schuitemaker H; van 't Wout AB
    J Hosp Infect; 2007 Aug; 66(4):332-8. PubMed ID: 17601636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an EvaGreen-based multiplex real-time PCR assay with melting curve analysis for simultaneous detection and differentiation of six viral pathogens of porcine reproductive and respiratory disorder.
    Rao P; Wu H; Jiang Y; Opriessnig T; Zheng X; Mo Y; Yang Z
    J Virol Methods; 2014 Nov; 208():56-62. PubMed ID: 25102430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of mouse minute virus inactivation by high temperature short time treatment technology: a statistical assessment.
    Murphy M; Quesada GM; Chen D
    Biologicals; 2011 Nov; 39(6):438-43. PubMed ID: 21985900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of the production process of SURFACEN(®) to inactivate and remove virus.
    Sánchez Y; Noa E; Alfonso W; Dubed M; Alvarez G; Navea L; Montes de Oca N; Lobaina L; Díaz E
    Biologicals; 2013 Jul; 41(4):254-60. PubMed ID: 23665304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine.
    Lackner C; Leydold SM; Modrof J; Farcet MR; Grillberger L; Schäfer B; Anderle H; Kreil TR
    Vaccine; 2014 Apr; 32(18):2056-61. PubMed ID: 24560672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of viral inactivation during pH 3.3 pepsin digestion and caprylic acid treatment of antivenoms.
    Burnouf T; Terpstra F; Habib G; Seddik S
    Biologicals; 2007 Oct; 35(4):329-34. PubMed ID: 17363271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus survival in slurry: analysis of the stability of foot-and-mouth disease, classical swine fever, bovine viral diarrhoea and swine influenza viruses.
    Bøtner A; Belsham GJ
    Vet Microbiol; 2012 May; 157(1-2):41-9. PubMed ID: 22226541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat.
    Borovec S; Broumis C; Adcock W; Fang R; Uren E
    Biologicals; 1998 Sep; 26(3):237-44. PubMed ID: 10208725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of multiplex PCR for simultaneous detection of six swine DNA and RNA viruses.
    Xu XG; Chen GD; Huang Y; Ding L; Li ZC; Chang CD; Wang CY; Tong DW; Liu HJ
    J Virol Methods; 2012 Jul; 183(1):69-74. PubMed ID: 22575688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral safety of APOSECTM: a novel peripheral blood mononuclear cell derived-biological for regenerative medicine.
    Gugerell A; Sorgenfrey D; Laggner M; Raimann J; Peterbauer A; Bormann D; Suessner S; Gabriel C; Moser B; Ostler T; Mildner M; Ankersmit HJ
    Blood Transfus; 2020 Jan; 18(1):30-39. PubMed ID: 30865581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration.
    Troccoli NM; McIver J; Losikoff A; Poiley J
    Biologicals; 1998 Dec; 26(4):321-9. PubMed ID: 10403036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraviolet-C irradiation for inactivation of viruses in foetal bovine serum.
    Vaidya V; Dhere R; Agnihotri S; Muley R; Patil S; Pawar A
    Vaccine; 2018 Jul; 36(29):4215-4221. PubMed ID: 29891350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis E virus derived from different sources exhibits different behaviour in virus inactivation and/or removal studies with plasma derivatives.
    Yunoki M; Tanaka H; Takahashi K; Urayama T; Hattori S; Ideno S; Furuki R; Sakai K; Hagiwara K; Ikuta K
    Biologicals; 2016 Sep; 44(5):403-11. PubMed ID: 27461242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.